Coronavirus (COVID-19)

A study has found COVID-19 nearly doubles a person’s risk of developing Alzheimer’s disease in the year following infection. The findings add to a body of research indicating SARS-CoV-2 infections can affect progression of neurodegenerative disease.

A new study has added to the growing body of evidence reporting similarities between long COVID and chronic fatigue syndrome (ME/CFS). The research found around half of the long COVID patients studied fit the diagnostic criteria for ME/CFS.

The FDA has authorized new mRNA booster shots targeting the BA.4 and BA.5 Omicron variants of SARS-CoV-2. The authorization marks the first updated COVID-19 vaccines to be made available in the US since the original vaccines became available in late 2020.

RMIT scientists are looking to help tackle the mounting waste generated by the ongoing pandemic, by demonstrating a form of concrete that incorporates shredded personal protective equipment (PPE) for improved performance.

A study has homed in on a part of the SARS-CoV-2 spike protein that is shared across all variants. The research reveals an antibody fragment that can block the virus from entering human cells, paving the way for therapies to neutralize all variants.

New research has offered the most comprehensive look at the long-term neurological effects of COVID-19 to date, tracking more than one million people and finding increased rates of dementia can be detected up to 24 months after the acute disease.

Regulators in the UK have approved Moderna’s new Omicron-specific COVID-19 vaccine for an upcoming nation-wide autumn booster program. The approval makes the UK the first region in the world to move forward with an improved variant-targeting vaccine.

An innovative new rapid test promises to give people the ability to easily measure their COVID-19 immunity. The test tracks levels of neutralizing antibodies in a drop of blood, helping a person evaluate their susceptibility to SARS-CoV-2 infection.

A huge new study looking at the symptoms of long COVID in non-hospitalized patients has identified a diverse set of symptoms, including reduced libido and hair loss, and suggested reclassifying the condition into three distinct groups.

For the last few years, Kevin Ngo has spent his spare time developing a new kind of reusable face mask. The resulting Flo Mask is a radically different take on face masks: light, comfortable, and as protective as any disposable mask around.

What if a fitness tracker sitting on your wrist could detect COVID-19 before you even developed symptoms? A study claims this is not only possible, but preliminary investigations found infections can be detected two days before symptoms appear.

New research published in JAMA Network Open offers new insights into the risk children face from long COVID. The findings reveal long COVID is relatively rare in children, and most prevalent in hospitalized adolescents over the age of 14.